Cedars-Sinai Cancer

Hi Norma, your kind words about your experience at Cedars-Sinai Cancer are very much appreciated! Thank you for sharing your experience with us.

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support.
jobs.cshs.org#en/sites/CX_...

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.

Alessio Pigazzi, expert in robot-assisted techniques, selected as new colorectal surgery leader at Cedars-Sinai (@cedarssinaicancer.bsky.social)
https://cancerletter.com/in-brief/20251003_8c/

The Cedars-Sinai Cancer: Adolescents and Young Adult Cancer Conference will take place on 10/11 at the Marina Del Rey Marriott with updates on best practices for multi-disciplinary management of adolescent and young adult cancer.
cedars.cloud-cme.com/course/cours...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more. clinicaltrials.cedars-sinai.edu/view/6118637...

Our fourth cohort of Undergraduates Gaining Research Opportunities for the Cancer Workforce (U-GROW) Program research internships was completed this summer! Congratulations to all of the promising young researchers!

We’ re proud our Cancer Research Training and Education Coordination Office in partnership with YMCA Metro LA held the Beyond the Books: High School Healthcare Career Exploration Program this summer with 24 high school students learning about cancer research!

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support.
jobs.cshs.org#en/sites/CX_...

Check the latest cancer-related publications from Cedars-Sinai and Cedars-Sinai Cancer clinicians and researchers! Follow this link on LinkedIn for a listing of these cutting-edge research papers.
www.linkedin.com/posts/cedars...

Cedars-Sinai Cancer clinicians and researchers are sharing their expertise in a variety of interviews and articles on a wide range of topics! Follow this link on LinkedIn to see the latest news on their work.
www.linkedin.com/pulse/cedars...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer This cohort study examines the prevalence of pathogenic or likely pathogenic variants in BRCA1 and BRCA2 in women with breast cancer in a racially and ethnically diverse population.

What is the prevalence of #BRCA pathogenic or likely (P/LP) variants in an unselected population of women with #breastcancer? Via @jamanetworkopen.com @cedarssinaicancer.bsky.social

#hereditarycancer #BCSM #womenshealth #genetics #cancerresearch #medsky

Fab closing presentation by friend and #mathonco agitator @gliomath.bsky.social from @cedarssinaicancer.bsky.social presenting cool new work, Every Patient Deserves Their Own Equation: Towards Digital Twins for Neuro-Oncology.

Breast Cancer Overview - American Association for Cancer Research (AACR) More than 250,000 women a year are diagnosed with breast cancer in the U.S. Learn about the prevention, screening, and treatment options for breast cancer.

ER-positive, HER2-negative is the most common subtype of breast cancer. Learn more about prevention, screening, and treatment options for breast: buff.ly/dYFDLF1

Image of Cedars-Sinai hospital and US News Honor Roll badge as Top US Hospital for 10th consecutive year

We are proud to have Cedars Sinai recognized in the Honor Roll of the U.S. News & World Report's Annual "Best Hospitals" Rankings for the 10th consecutive year and tied for #1 in California and #1 in Los Angeles! @usnews.com
www.cedars-sinai.org/newsroom/ced...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

We are seeking a Research Project Advisor to support our Community Outreach and Engagement program! Applicants should have a BS or MS in Biomedical Sciences, Public Health, Research, or related field & 7+ years in research program & project support.
jobs.cshs.org#en/sites/CX_...

Cedars-Sinai Cancer clinicians and researchers will be at The American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting 9/27-10/1! See the highlight schedule for their presentations and activities at the meeting. @astro-org.bsky.social #ASTRO25

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.
clinicaltrials.cedars-sinai.edu/view/IIT2022...

Reflections of a cancer scientist Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - The Cancer Letter What inspires us? What gets us excited? What causes us to devote our life to a cause? The unknown, a hope for better options, the drive to discover. Example? Look at where our understanding of cancer was two, five, 10, 15, 20, or more years ago and then consider what has happened over the past […]

Ze’ev Ronai, MD: "We simply did not realize how important the environment is for tumor development and the enormous role played by immune responses and the tumor microenvironment."
https://cancerletter.com/guest-editorial/20250912_2/

Dr. Vladimir Ljubimov is first author on the Journal of Controlled Release paper describing a new therapeutic system developed with the help of AI that significantly improved survival of laboratory mice with primary central nervous system lymphoma.
www.cedars-sinai.org/newsroom/ai-...

Do you have EGFR-Mutated #NonSmallCellLungCancer and are considering treatment? You may be eligible for the #Copernicus clinical trial. Follow the link below or call (424)-312-0745 to learn more.
clinicaltrials.cedars-sinai.edu/view/6118637...

The International Association for the Study of Lung Cancer @iaslc.bsky.social Lung Cancer News covered the results of the Phase III Pragmatica-Lung trial presented at the 2025 ASCO @ascocancer.bsky.social annual meeting by Dr. Karen Reckamp.
www.ilcn.org/a-pragmatic-...

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.
clinicaltrials.cedars-sinai.edu/view/IIT2022...

Reflections of a cancer scientist Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - The Cancer Letter What inspires us? What gets us excited? What causes us to devote our life to a cause? The unknown, a hope for better options, the drive to discover. Example? Look at where our understanding of cancer was two, five, 10, 15, 20, or more years ago and then consider what has happened over the past […]

"Look at where our understanding of cancer was...20, or more years ago and then consider what has happened over the past two decades. We finally realized how more complex the problem of cancer is—more than any of us imagined."- Ze’ev Ronai, MD
https://cancerletter.com/guest-editorial/20250912_2/

Reflections of a cancer scientist Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - The Cancer Letter What inspires us? What gets us excited? What causes us to devote our life to a cause? The unknown, a hope for better options, the drive to discover. Example? Look at where our understanding of cancer was two, five, 10, 15, 20, or more years ago and then consider what has happened over the past […]

Reflections of a cancer scientist. Guest editorial by Ze’ev Ronai @cedarssinaicancer.bsky.social
https://cancerletter.com/guest-editorial/20250912_2/

This summer, our Community Outreach and Engagement program hosted the survivorship event “Communities Overcoming Cancer Together and Facing Life After a Diagnosis” with partners American Cancer Society, Anthem, Blood Cancer United, and the Cancer Support Community. Our thanks to everyone involved!

Do you have metastatic triple negative breast cancer #TNBC that has grown or spread after treatment? You may be eligible for the #YUANTNBC clinical trial. Follow the link below or call (414)-314-0471 to learn more.

clinicaltrials.cedars-sinai.edu/view/IIT2022...

Our newsroom shares the extraordinary story of one of our patients who was suffering from a massive 40-pound tumor pressing against her lungs and heart. Dr. Cristina Ferrone brought together a team who successfully removed the tumor after a 14 hour surgery.
www.cedars-sinai.org/newsroom/bri...